Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients

BACKGROUND: COVID-19 represents one of the most significant medical problems of our time. AIMS: This study is focused on the question whether patients with inflammatory bowel disease (IBD) who receive immunotherapies are more vulnerable to respiratory tract infections and SARS-CoV-2 infections in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Waggershauser, Constanze Heike, Tillack-Schreiber, Cornelia, Weyh, Paul, Alt, Eckard, Siegmund, Thorsten, Berchthold-Benchieb, Christine, Szokodi, Daniel, Schnitzler, Fabian, Ochsenkühn, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433291/
https://www.ncbi.nlm.nih.gov/pubmed/36060521
http://dx.doi.org/10.1155/2022/3469789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433291/
https://www.ncbi.nlm.nih.gov/pubmed/36060521
http://dx.doi.org/10.1155/2022/3469789

Ejemplares similares